nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—OPRD1—epilepsy syndrome	0.28	0.566	CbGaD
Sufentanil—OPRM1—epilepsy syndrome	0.215	0.433	CbGaD
Sufentanil—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0217	0.0879	CbGbCtD
Sufentanil—CYP3A4—Trimethadione—epilepsy syndrome	0.0202	0.0817	CbGbCtD
Sufentanil—CYP3A4—Felbamate—epilepsy syndrome	0.0202	0.0817	CbGbCtD
Sufentanil—CYP3A4—Fosphenytoin—epilepsy syndrome	0.019	0.0768	CbGbCtD
Sufentanil—CYP3A4—Clonazepam—epilepsy syndrome	0.0171	0.0694	CbGbCtD
Sufentanil—CYP3A4—Clobazam—epilepsy syndrome	0.0164	0.0666	CbGbCtD
Sufentanil—CYP3A4—Rufinamide—epilepsy syndrome	0.014	0.0566	CbGbCtD
Sufentanil—CYP3A4—Carbamazepine—epilepsy syndrome	0.0136	0.0552	CbGbCtD
Sufentanil—CYP3A4—Primidone—epilepsy syndrome	0.0127	0.0515	CbGbCtD
Sufentanil—CYP3A4—Phenytoin—epilepsy syndrome	0.0122	0.0495	CbGbCtD
Sufentanil—CYP3A4—Propofol—epilepsy syndrome	0.0114	0.0462	CbGbCtD
Sufentanil—CYP3A4—Acetazolamide—epilepsy syndrome	0.0109	0.0441	CbGbCtD
Sufentanil—CYP3A4—Phenobarbital—epilepsy syndrome	0.0109	0.0441	CbGbCtD
Sufentanil—CYP3A4—Midazolam—epilepsy syndrome	0.0107	0.0435	CbGbCtD
Sufentanil—CYP3A4—Diazepam—epilepsy syndrome	0.0103	0.0418	CbGbCtD
Sufentanil—CYP3A4—Zonisamide—epilepsy syndrome	0.0101	0.0408	CbGbCtD
Sufentanil—CYP3A4—Valproic Acid—epilepsy syndrome	0.00814	0.033	CbGbCtD
Sufentanil—CYP3A4—Topiramate—epilepsy syndrome	0.00734	0.0297	CbGbCtD
Sufentanil—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00381	0.14	CbGeAlD
Sufentanil—OPRD1—ganglion—epilepsy syndrome	0.00348	0.128	CbGeAlD
Sufentanil—OPRM1—ganglion—epilepsy syndrome	0.00237	0.0873	CbGeAlD
Sufentanil—OPRD1—forebrain—epilepsy syndrome	0.00146	0.0537	CbGeAlD
Sufentanil—OPRK1—forebrain—epilepsy syndrome	0.0014	0.0515	CbGeAlD
Sufentanil—OPRD1—telencephalon—epilepsy syndrome	0.00134	0.0494	CbGeAlD
Sufentanil—OPRM1—brainstem—epilepsy syndrome	0.00103	0.038	CbGeAlD
Sufentanil—OPRM1—forebrain—epilepsy syndrome	0.000995	0.0366	CbGeAlD
Sufentanil—Remifentanil—OPRD1—epilepsy syndrome	0.000955	0.244	CrCbGaD
Sufentanil—OPRM1—telencephalon—epilepsy syndrome	0.000915	0.0337	CbGeAlD
Sufentanil—OPRD1—head—epilepsy syndrome	0.000835	0.0308	CbGeAlD
Sufentanil—OPRK1—head—epilepsy syndrome	0.0008	0.0295	CbGeAlD
Sufentanil—OPRD1—nervous system—epilepsy syndrome	0.000792	0.0292	CbGeAlD
Sufentanil—OPRD1—central nervous system—epilepsy syndrome	0.000762	0.0281	CbGeAlD
Sufentanil—OPRK1—nervous system—epilepsy syndrome	0.000759	0.028	CbGeAlD
Sufentanil—OPRK1—central nervous system—epilepsy syndrome	0.000731	0.0269	CbGeAlD
Sufentanil—Remifentanil—OPRM1—epilepsy syndrome	0.000731	0.186	CrCbGaD
Sufentanil—OPRK1—cerebellum—epilepsy syndrome	0.000714	0.0263	CbGeAlD
Sufentanil—Anileridine—OPRM1—epilepsy syndrome	0.000712	0.182	CrCbGaD
Sufentanil—OPRM1—midbrain—epilepsy syndrome	0.000657	0.0242	CbGeAlD
Sufentanil—OPRM1—spinal cord—epilepsy syndrome	0.000641	0.0236	CbGeAlD
Sufentanil—Alfentanil—OPRM1—epilepsy syndrome	0.000605	0.154	CrCbGaD
Sufentanil—OPRD1—brain—epilepsy syndrome	0.000605	0.0223	CbGeAlD
Sufentanil—OPRK1—brain—epilepsy syndrome	0.00058	0.0214	CbGeAlD
Sufentanil—OPRM1—head—epilepsy syndrome	0.000569	0.021	CbGeAlD
Sufentanil—OPRM1—nervous system—epilepsy syndrome	0.00054	0.0199	CbGeAlD
Sufentanil—OPRM1—central nervous system—epilepsy syndrome	0.00052	0.0191	CbGeAlD
Sufentanil—OPRM1—brain—epilepsy syndrome	0.000413	0.0152	CbGeAlD
Sufentanil—Fentanyl—OPRD1—epilepsy syndrome	0.00029	0.0739	CrCbGaD
Sufentanil—Fentanyl—OPRM1—epilepsy syndrome	0.000222	0.0566	CrCbGaD
Sufentanil—CYP3A4—nervous system—epilepsy syndrome	0.00022	0.0081	CbGeAlD
Sufentanil—CYP3A4—central nervous system—epilepsy syndrome	0.000212	0.0078	CbGeAlD
Sufentanil—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000192	0.00131	CcSEcCtD
Sufentanil—Confusional state—Oxcarbazepine—epilepsy syndrome	0.000191	0.0013	CcSEcCtD
Sufentanil—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.00019	0.0013	CcSEcCtD
Sufentanil—Hypotension—Felbamate—epilepsy syndrome	0.00019	0.0013	CcSEcCtD
Sufentanil—Somnolence—Vigabatrin—epilepsy syndrome	0.000189	0.00129	CcSEcCtD
Sufentanil—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000189	0.00129	CcSEcCtD
Sufentanil—Feeling abnormal—Midazolam—epilepsy syndrome	0.000189	0.00129	CcSEcCtD
Sufentanil—Urinary retention—Topiramate—epilepsy syndrome	0.000188	0.00128	CcSEcCtD
Sufentanil—Nausea—Phenobarbital—epilepsy syndrome	0.000188	0.00128	CcSEcCtD
Sufentanil—Dizziness—Clobazam—epilepsy syndrome	0.000187	0.00128	CcSEcCtD
Sufentanil—Tachycardia—Clonazepam—epilepsy syndrome	0.000187	0.00128	CcSEcCtD
Sufentanil—Feeling abnormal—Levetiracetam—epilepsy syndrome	0.000187	0.00127	CcSEcCtD
Sufentanil—Somnolence—Diazepam—epilepsy syndrome	0.000187	0.00127	CcSEcCtD
Sufentanil—Hypotension—Zonisamide—epilepsy syndrome	0.000186	0.00127	CcSEcCtD
Sufentanil—Tachycardia—Phenytoin—epilepsy syndrome	0.000186	0.00127	CcSEcCtD
Sufentanil—Hypertension—Lamotrigine—epilepsy syndrome	0.000186	0.00127	CcSEcCtD
Sufentanil—Vomiting—Lacosamide—epilepsy syndrome	0.000186	0.00127	CcSEcCtD
Sufentanil—Body temperature increased—Propofol—epilepsy syndrome	0.000185	0.00127	CcSEcCtD
Sufentanil—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000185	0.00126	CcSEcCtD
Sufentanil—Nausea—Rufinamide—epilepsy syndrome	0.000185	0.00126	CcSEcCtD
Sufentanil—Rash—Lacosamide—epilepsy syndrome	0.000184	0.00126	CcSEcCtD
Sufentanil—Dermatitis—Lacosamide—epilepsy syndrome	0.000184	0.00125	CcSEcCtD
Sufentanil—Confusional state—Carbamazepine—epilepsy syndrome	0.000183	0.00125	CcSEcCtD
Sufentanil—Headache—Lacosamide—epilepsy syndrome	0.000183	0.00125	CcSEcCtD
Sufentanil—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000182	0.00124	CcSEcCtD
Sufentanil—Bradycardia—Pregabalin—epilepsy syndrome	0.000181	0.00123	CcSEcCtD
Sufentanil—Somnolence—Felbamate—epilepsy syndrome	0.000181	0.00123	CcSEcCtD
Sufentanil—Feeling abnormal—Fosphenytoin—epilepsy syndrome	0.00018	0.00123	CcSEcCtD
Sufentanil—Vomiting—Clobazam—epilepsy syndrome	0.00018	0.00123	CcSEcCtD
Sufentanil—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000179	0.00122	CcSEcCtD
Sufentanil—Hypotension—Clonazepam—epilepsy syndrome	0.000179	0.00122	CcSEcCtD
Sufentanil—Rash—Clobazam—epilepsy syndrome	0.000179	0.00122	CcSEcCtD
Sufentanil—Dermatitis—Clobazam—epilepsy syndrome	0.000178	0.00122	CcSEcCtD
Sufentanil—Hypotension—Phenytoin—epilepsy syndrome	0.000178	0.00121	CcSEcCtD
Sufentanil—Headache—Clobazam—epilepsy syndrome	0.000177	0.00121	CcSEcCtD
Sufentanil—Tachycardia—Carbamazepine—epilepsy syndrome	0.000177	0.00121	CcSEcCtD
Sufentanil—Confusional state—Lamotrigine—epilepsy syndrome	0.000177	0.00121	CcSEcCtD
Sufentanil—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000177	0.00121	CcSEcCtD
Sufentanil—Somnolence—Zonisamide—epilepsy syndrome	0.000177	0.00121	CcSEcCtD
Sufentanil—Chills—Valproic Acid—epilepsy syndrome	0.000176	0.0012	CcSEcCtD
Sufentanil—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.000176	0.0012	CcSEcCtD
Sufentanil—Alfentanil—ALB—epilepsy syndrome	0.000175	0.0448	CrCbGaD
Sufentanil—Arrhythmia—Valproic Acid—epilepsy syndrome	0.000175	0.0012	CcSEcCtD
Sufentanil—Urinary tract disorder—Pregabalin—epilepsy syndrome	0.000175	0.0012	CcSEcCtD
Sufentanil—Urethral disorder—Pregabalin—epilepsy syndrome	0.000174	0.00119	CcSEcCtD
Sufentanil—Nausea—Lacosamide—epilepsy syndrome	0.000173	0.00118	CcSEcCtD
Sufentanil—Feeling abnormal—Diazepam—epilepsy syndrome	0.000173	0.00118	CcSEcCtD
Sufentanil—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000173	0.00118	CcSEcCtD
Sufentanil—Tachycardia—Lamotrigine—epilepsy syndrome	0.000171	0.00117	CcSEcCtD
Sufentanil—Somnolence—Clonazepam—epilepsy syndrome	0.00017	0.00116	CcSEcCtD
Sufentanil—Hypotension—Carbamazepine—epilepsy syndrome	0.00017	0.00116	CcSEcCtD
Sufentanil—Somnolence—Phenytoin—epilepsy syndrome	0.000169	0.00115	CcSEcCtD
Sufentanil—Hypersensitivity—Midazolam—epilepsy syndrome	0.000169	0.00115	CcSEcCtD
Sufentanil—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000168	0.00115	CcSEcCtD
Sufentanil—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000168	0.00115	CcSEcCtD
Sufentanil—Nausea—Clobazam—epilepsy syndrome	0.000168	0.00115	CcSEcCtD
Sufentanil—Alfentanil—ABCB1—epilepsy syndrome	0.000167	0.0427	CrCbGaD
Sufentanil—Feeling abnormal—Felbamate—epilepsy syndrome	0.000167	0.00114	CcSEcCtD
Sufentanil—Dizziness—Acetazolamide—epilepsy syndrome	0.000167	0.00114	CcSEcCtD
Sufentanil—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000167	0.00114	CcSEcCtD
Sufentanil—Pruritus—Propofol—epilepsy syndrome	0.000166	0.00113	CcSEcCtD
Sufentanil—Bradycardia—Gabapentin—epilepsy syndrome	0.000166	0.00113	CcSEcCtD
Sufentanil—Feeling abnormal—Zonisamide—epilepsy syndrome	0.000164	0.00112	CcSEcCtD
Sufentanil—Pruritus—Midazolam—epilepsy syndrome	0.000162	0.00111	CcSEcCtD
Sufentanil—Somnolence—Carbamazepine—epilepsy syndrome	0.000161	0.0011	CcSEcCtD
Sufentanil—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.000161	0.0011	CcSEcCtD
Sufentanil—Body temperature increased—Felbamate—epilepsy syndrome	0.000161	0.0011	CcSEcCtD
Sufentanil—Vomiting—Acetazolamide—epilepsy syndrome	0.00016	0.0011	CcSEcCtD
Sufentanil—Pruritus—Levetiracetam—epilepsy syndrome	0.00016	0.00109	CcSEcCtD
Sufentanil—Urethral disorder—Gabapentin—epilepsy syndrome	0.00016	0.00109	CcSEcCtD
Sufentanil—Chills—Pregabalin—epilepsy syndrome	0.000159	0.00109	CcSEcCtD
Sufentanil—Arrhythmia—Pregabalin—epilepsy syndrome	0.000159	0.00108	CcSEcCtD
Sufentanil—Headache—Acetazolamide—epilepsy syndrome	0.000158	0.00108	CcSEcCtD
Sufentanil—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000158	0.00108	CcSEcCtD
Sufentanil—Body temperature increased—Zonisamide—epilepsy syndrome	0.000157	0.00107	CcSEcCtD
Sufentanil—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000157	0.00107	CcSEcCtD
Sufentanil—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000157	0.00107	CcSEcCtD
Sufentanil—Somnolence—Lamotrigine—epilepsy syndrome	0.000156	0.00107	CcSEcCtD
Sufentanil—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000156	0.00106	CcSEcCtD
Sufentanil—Dizziness—Propofol—epilepsy syndrome	0.000155	0.00106	CcSEcCtD
Sufentanil—Pruritus—Fosphenytoin—epilepsy syndrome	0.000155	0.00106	CcSEcCtD
Sufentanil—Hypersensitivity—Diazepam—epilepsy syndrome	0.000155	0.00106	CcSEcCtD
Sufentanil—Dizziness—Midazolam—epilepsy syndrome	0.000152	0.00104	CcSEcCtD
Sufentanil—Body temperature increased—Clonazepam—epilepsy syndrome	0.000151	0.00103	CcSEcCtD
Sufentanil—Pruritus—Vigabatrin—epilepsy syndrome	0.000151	0.00103	CcSEcCtD
Sufentanil—Body temperature increased—Phenytoin—epilepsy syndrome	0.00015	0.00103	CcSEcCtD
Sufentanil—Nausea—Acetazolamide—epilepsy syndrome	0.00015	0.00102	CcSEcCtD
Sufentanil—Dizziness—Levetiracetam—epilepsy syndrome	0.00015	0.00102	CcSEcCtD
Sufentanil—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.00015	0.00102	CcSEcCtD
Sufentanil—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.00015	0.00102	CcSEcCtD
Sufentanil—Vomiting—Propofol—epilepsy syndrome	0.000149	0.00102	CcSEcCtD
Sufentanil—Pruritus—Diazepam—epilepsy syndrome	0.000148	0.00101	CcSEcCtD
Sufentanil—Rash—Propofol—epilepsy syndrome	0.000148	0.00101	CcSEcCtD
Sufentanil—Dermatitis—Propofol—epilepsy syndrome	0.000148	0.00101	CcSEcCtD
Sufentanil—Hypertension—Valproic Acid—epilepsy syndrome	0.000148	0.00101	CcSEcCtD
Sufentanil—Headache—Propofol—epilepsy syndrome	0.000147	0.001	CcSEcCtD
Sufentanil—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000146	0.001	CcSEcCtD
Sufentanil—Chills—Gabapentin—epilepsy syndrome	0.000146	0.000997	CcSEcCtD
Sufentanil—Vomiting—Midazolam—epilepsy syndrome	0.000146	0.000996	CcSEcCtD
Sufentanil—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000145	0.000987	CcSEcCtD
Sufentanil—Rash—Midazolam—epilepsy syndrome	0.000145	0.000987	CcSEcCtD
Sufentanil—Dizziness—Fosphenytoin—epilepsy syndrome	0.000145	0.000987	CcSEcCtD
Sufentanil—Dermatitis—Midazolam—epilepsy syndrome	0.000145	0.000986	CcSEcCtD
Sufentanil—Vomiting—Levetiracetam—epilepsy syndrome	0.000144	0.000983	CcSEcCtD
Sufentanil—Headache—Midazolam—epilepsy syndrome	0.000144	0.000981	CcSEcCtD
Sufentanil—Pruritus—Felbamate—epilepsy syndrome	0.000144	0.000981	CcSEcCtD
Sufentanil—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000144	0.00098	CcSEcCtD
Sufentanil—Rash—Levetiracetam—epilepsy syndrome	0.000143	0.000975	CcSEcCtD
Sufentanil—Dermatitis—Levetiracetam—epilepsy syndrome	0.000143	0.000974	CcSEcCtD
Sufentanil—Headache—Levetiracetam—epilepsy syndrome	0.000142	0.000969	CcSEcCtD
Sufentanil—Erythema—Gabapentin—epilepsy syndrome	0.000142	0.000967	CcSEcCtD
Sufentanil—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000141	0.000963	CcSEcCtD
Sufentanil—Dizziness—Vigabatrin—epilepsy syndrome	0.000141	0.000962	CcSEcCtD
Sufentanil—Confusional state—Valproic Acid—epilepsy syndrome	0.000141	0.00096	CcSEcCtD
Sufentanil—Pruritus—Zonisamide—epilepsy syndrome	0.000141	0.00096	CcSEcCtD
Sufentanil—Hypersensitivity—Phenytoin—epilepsy syndrome	0.00014	0.000957	CcSEcCtD
Sufentanil—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000139	0.000952	CcSEcCtD
Sufentanil—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000139	0.000952	CcSEcCtD
Sufentanil—Bradycardia—Topiramate—epilepsy syndrome	0.000139	0.000952	CcSEcCtD
Sufentanil—Nausea—Propofol—epilepsy syndrome	0.000139	0.000951	CcSEcCtD
Sufentanil—Vomiting—Fosphenytoin—epilepsy syndrome	0.000139	0.000949	CcSEcCtD
Sufentanil—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000139	0.000947	CcSEcCtD
Sufentanil—Dizziness—Diazepam—epilepsy syndrome	0.000139	0.000947	CcSEcCtD
Sufentanil—Rash—Fosphenytoin—epilepsy syndrome	0.000138	0.000941	CcSEcCtD
Sufentanil—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000138	0.00094	CcSEcCtD
Sufentanil—Headache—Fosphenytoin—epilepsy syndrome	0.000137	0.000935	CcSEcCtD
Sufentanil—Nausea—Midazolam—epilepsy syndrome	0.000136	0.00093	CcSEcCtD
Sufentanil—Tachycardia—Valproic Acid—epilepsy syndrome	0.000136	0.000929	CcSEcCtD
Sufentanil—Pruritus—Clonazepam—epilepsy syndrome	0.000136	0.000925	CcSEcCtD
Sufentanil—Vomiting—Vigabatrin—epilepsy syndrome	0.000135	0.000925	CcSEcCtD
Sufentanil—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000135	0.000923	CcSEcCtD
Sufentanil—Pruritus—Phenytoin—epilepsy syndrome	0.000135	0.000919	CcSEcCtD
Sufentanil—Nausea—Levetiracetam—epilepsy syndrome	0.000135	0.000919	CcSEcCtD
Sufentanil—Rash—Vigabatrin—epilepsy syndrome	0.000134	0.000917	CcSEcCtD
Sufentanil—Dizziness—Felbamate—epilepsy syndrome	0.000134	0.000917	CcSEcCtD
Sufentanil—Dermatitis—Vigabatrin—epilepsy syndrome	0.000134	0.000916	CcSEcCtD
Sufentanil—Urethral disorder—Topiramate—epilepsy syndrome	0.000134	0.000916	CcSEcCtD
Sufentanil—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000134	0.000914	CcSEcCtD
Sufentanil—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000134	0.000914	CcSEcCtD
Sufentanil—Headache—Vigabatrin—epilepsy syndrome	0.000134	0.000911	CcSEcCtD
Sufentanil—Hypertension—Pregabalin—epilepsy syndrome	0.000133	0.000911	CcSEcCtD
Sufentanil—Vomiting—Diazepam—epilepsy syndrome	0.000133	0.000911	CcSEcCtD
Sufentanil—Rash—Diazepam—epilepsy syndrome	0.000132	0.000903	CcSEcCtD
Sufentanil—Dermatitis—Diazepam—epilepsy syndrome	0.000132	0.000902	CcSEcCtD
Sufentanil—Dizziness—Zonisamide—epilepsy syndrome	0.000131	0.000897	CcSEcCtD
Sufentanil—Headache—Diazepam—epilepsy syndrome	0.000131	0.000897	CcSEcCtD
Sufentanil—Hypotension—Valproic Acid—epilepsy syndrome	0.00013	0.00089	CcSEcCtD
Sufentanil—Nausea—Fosphenytoin—epilepsy syndrome	0.00013	0.000887	CcSEcCtD
Sufentanil—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000129	0.000883	CcSEcCtD
Sufentanil—Vomiting—Felbamate—epilepsy syndrome	0.000129	0.000881	CcSEcCtD
Sufentanil—Pruritus—Carbamazepine—epilepsy syndrome	0.000129	0.000877	CcSEcCtD
Sufentanil—Rash—Felbamate—epilepsy syndrome	0.000128	0.000874	CcSEcCtD
Sufentanil—Dermatitis—Felbamate—epilepsy syndrome	0.000128	0.000873	CcSEcCtD
Sufentanil—Headache—Felbamate—epilepsy syndrome	0.000127	0.000868	CcSEcCtD
Sufentanil—Confusional state—Pregabalin—epilepsy syndrome	0.000127	0.000868	CcSEcCtD
Sufentanil—Dizziness—Clonazepam—epilepsy syndrome	0.000127	0.000865	CcSEcCtD
Sufentanil—Nausea—Vigabatrin—epilepsy syndrome	0.000127	0.000864	CcSEcCtD
Sufentanil—Vomiting—Zonisamide—epilepsy syndrome	0.000126	0.000863	CcSEcCtD
Sufentanil—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000126	0.000861	CcSEcCtD
Sufentanil—Dizziness—Phenytoin—epilepsy syndrome	0.000126	0.000859	CcSEcCtD
Sufentanil—Rash—Zonisamide—epilepsy syndrome	0.000125	0.000856	CcSEcCtD
Sufentanil—Dermatitis—Zonisamide—epilepsy syndrome	0.000125	0.000855	CcSEcCtD
Sufentanil—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000125	0.000854	CcSEcCtD
Sufentanil—Nausea—Diazepam—epilepsy syndrome	0.000125	0.000851	CcSEcCtD
Sufentanil—Headache—Zonisamide—epilepsy syndrome	0.000125	0.00085	CcSEcCtD
Sufentanil—Pruritus—Lamotrigine—epilepsy syndrome	0.000124	0.000848	CcSEcCtD
Sufentanil—Somnolence—Valproic Acid—epilepsy syndrome	0.000124	0.000847	CcSEcCtD
Sufentanil—Tachycardia—Pregabalin—epilepsy syndrome	0.000123	0.00084	CcSEcCtD
Sufentanil—Chills—Topiramate—epilepsy syndrome	0.000123	0.000839	CcSEcCtD
Sufentanil—Hypertension—Gabapentin—epilepsy syndrome	0.000122	0.000835	CcSEcCtD
Sufentanil—Vomiting—Clonazepam—epilepsy syndrome	0.000122	0.000831	CcSEcCtD
Sufentanil—Vomiting—Phenytoin—epilepsy syndrome	0.000121	0.000826	CcSEcCtD
Sufentanil—Rash—Clonazepam—epilepsy syndrome	0.000121	0.000825	CcSEcCtD
Sufentanil—Dermatitis—Clonazepam—epilepsy syndrome	0.000121	0.000824	CcSEcCtD
Sufentanil—Nausea—Felbamate—epilepsy syndrome	0.000121	0.000823	CcSEcCtD
Sufentanil—Vomiting—Oxcarbazepine—epilepsy syndrome	0.00012	0.000822	CcSEcCtD
Sufentanil—Dizziness—Carbamazepine—epilepsy syndrome	0.00012	0.00082	CcSEcCtD
Sufentanil—Headache—Clonazepam—epilepsy syndrome	0.00012	0.000819	CcSEcCtD
Sufentanil—Rash—Phenytoin—epilepsy syndrome	0.00012	0.000819	CcSEcCtD
Sufentanil—Dermatitis—Phenytoin—epilepsy syndrome	0.00012	0.000818	CcSEcCtD
Sufentanil—Rash—Oxcarbazepine—epilepsy syndrome	0.000119	0.000815	CcSEcCtD
Sufentanil—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000119	0.000814	CcSEcCtD
Sufentanil—Headache—Phenytoin—epilepsy syndrome	0.000119	0.000814	CcSEcCtD
Sufentanil—Erythema—Topiramate—epilepsy syndrome	0.000119	0.000814	CcSEcCtD
Sufentanil—Headache—Oxcarbazepine—epilepsy syndrome	0.000119	0.000809	CcSEcCtD
Sufentanil—Nausea—Zonisamide—epilepsy syndrome	0.000118	0.000806	CcSEcCtD
Sufentanil—Hypotension—Pregabalin—epilepsy syndrome	0.000118	0.000804	CcSEcCtD
Sufentanil—Confusional state—Gabapentin—epilepsy syndrome	0.000117	0.000796	CcSEcCtD
Sufentanil—Dizziness—Lamotrigine—epilepsy syndrome	0.000116	0.000792	CcSEcCtD
Sufentanil—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000116	0.000789	CcSEcCtD
Sufentanil—Vomiting—Carbamazepine—epilepsy syndrome	0.000115	0.000788	CcSEcCtD
Sufentanil—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000115	0.000785	CcSEcCtD
Sufentanil—Rash—Carbamazepine—epilepsy syndrome	0.000115	0.000782	CcSEcCtD
Sufentanil—Dermatitis—Carbamazepine—epilepsy syndrome	0.000114	0.000781	CcSEcCtD
Sufentanil—Nausea—Clonazepam—epilepsy syndrome	0.000114	0.000777	CcSEcCtD
Sufentanil—Headache—Carbamazepine—epilepsy syndrome	0.000114	0.000777	CcSEcCtD
Sufentanil—Nausea—Phenytoin—epilepsy syndrome	0.000113	0.000772	CcSEcCtD
Sufentanil—Tachycardia—Gabapentin—epilepsy syndrome	0.000113	0.00077	CcSEcCtD
Sufentanil—Nausea—Oxcarbazepine—epilepsy syndrome	0.000112	0.000767	CcSEcCtD
Sufentanil—Somnolence—Pregabalin—epilepsy syndrome	0.000112	0.000765	CcSEcCtD
Sufentanil—Vomiting—Lamotrigine—epilepsy syndrome	0.000112	0.000762	CcSEcCtD
Sufentanil—Rash—Lamotrigine—epilepsy syndrome	0.000111	0.000756	CcSEcCtD
Sufentanil—Dermatitis—Lamotrigine—epilepsy syndrome	0.000111	0.000755	CcSEcCtD
Sufentanil—Body temperature increased—Valproic Acid—epilepsy syndrome	0.00011	0.000753	CcSEcCtD
Sufentanil—Headache—Lamotrigine—epilepsy syndrome	0.00011	0.000751	CcSEcCtD
Sufentanil—Hypotension—Gabapentin—epilepsy syndrome	0.000108	0.000738	CcSEcCtD
Sufentanil—Nausea—Carbamazepine—epilepsy syndrome	0.000108	0.000736	CcSEcCtD
Sufentanil—Nausea—Lamotrigine—epilepsy syndrome	0.000104	0.000712	CcSEcCtD
Sufentanil—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000104	0.000709	CcSEcCtD
Sufentanil—Hypertension—Topiramate—epilepsy syndrome	0.000103	0.000703	CcSEcCtD
Sufentanil—Somnolence—Gabapentin—epilepsy syndrome	0.000103	0.000702	CcSEcCtD
Sufentanil—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000103	0.000702	CcSEcCtD
Sufentanil—Body temperature increased—Pregabalin—epilepsy syndrome	9.97e-05	0.000681	CcSEcCtD
Sufentanil—Pruritus—Valproic Acid—epilepsy syndrome	9.87e-05	0.000674	CcSEcCtD
Sufentanil—Confusional state—Topiramate—epilepsy syndrome	9.81e-05	0.00067	CcSEcCtD
Sufentanil—Feeling abnormal—Gabapentin—epilepsy syndrome	9.53e-05	0.000651	CcSEcCtD
Sufentanil—Tachycardia—Topiramate—epilepsy syndrome	9.49e-05	0.000648	CcSEcCtD
Sufentanil—Hypersensitivity—Pregabalin—epilepsy syndrome	9.29e-05	0.000634	CcSEcCtD
Sufentanil—Dizziness—Valproic Acid—epilepsy syndrome	9.22e-05	0.00063	CcSEcCtD
Sufentanil—Body temperature increased—Gabapentin—epilepsy syndrome	9.14e-05	0.000624	CcSEcCtD
Sufentanil—Hypotension—Topiramate—epilepsy syndrome	9.09e-05	0.000621	CcSEcCtD
Sufentanil—Pruritus—Pregabalin—epilepsy syndrome	8.92e-05	0.000609	CcSEcCtD
Sufentanil—Vomiting—Valproic Acid—epilepsy syndrome	8.87e-05	0.000605	CcSEcCtD
Sufentanil—Rash—Valproic Acid—epilepsy syndrome	8.8e-05	0.0006	CcSEcCtD
Sufentanil—Dermatitis—Valproic Acid—epilepsy syndrome	8.79e-05	0.0006	CcSEcCtD
Sufentanil—Headache—Valproic Acid—epilepsy syndrome	8.74e-05	0.000597	CcSEcCtD
Sufentanil—Somnolence—Topiramate—epilepsy syndrome	8.65e-05	0.00059	CcSEcCtD
Sufentanil—Hypersensitivity—Gabapentin—epilepsy syndrome	8.52e-05	0.000582	CcSEcCtD
Sufentanil—Dizziness—Pregabalin—epilepsy syndrome	8.34e-05	0.000569	CcSEcCtD
Sufentanil—Nausea—Valproic Acid—epilepsy syndrome	8.29e-05	0.000566	CcSEcCtD
Sufentanil—Pruritus—Gabapentin—epilepsy syndrome	8.18e-05	0.000558	CcSEcCtD
Sufentanil—Vomiting—Pregabalin—epilepsy syndrome	8.02e-05	0.000547	CcSEcCtD
Sufentanil—Feeling abnormal—Topiramate—epilepsy syndrome	8.02e-05	0.000547	CcSEcCtD
Sufentanil—Rash—Pregabalin—epilepsy syndrome	7.95e-05	0.000543	CcSEcCtD
Sufentanil—Dermatitis—Pregabalin—epilepsy syndrome	7.94e-05	0.000542	CcSEcCtD
Sufentanil—Headache—Pregabalin—epilepsy syndrome	7.9e-05	0.000539	CcSEcCtD
Sufentanil—Body temperature increased—Topiramate—epilepsy syndrome	7.69e-05	0.000525	CcSEcCtD
Sufentanil—Dizziness—Gabapentin—epilepsy syndrome	7.65e-05	0.000522	CcSEcCtD
Sufentanil—Nausea—Pregabalin—epilepsy syndrome	7.49e-05	0.000511	CcSEcCtD
Sufentanil—Vomiting—Gabapentin—epilepsy syndrome	7.35e-05	0.000502	CcSEcCtD
Sufentanil—Rash—Gabapentin—epilepsy syndrome	7.29e-05	0.000498	CcSEcCtD
Sufentanil—Dermatitis—Gabapentin—epilepsy syndrome	7.28e-05	0.000497	CcSEcCtD
Sufentanil—Headache—Gabapentin—epilepsy syndrome	7.24e-05	0.000495	CcSEcCtD
Sufentanil—Hypersensitivity—Topiramate—epilepsy syndrome	7.17e-05	0.000489	CcSEcCtD
Sufentanil—Pruritus—Topiramate—epilepsy syndrome	6.88e-05	0.00047	CcSEcCtD
Sufentanil—Nausea—Gabapentin—epilepsy syndrome	6.87e-05	0.000469	CcSEcCtD
Sufentanil—Dizziness—Topiramate—epilepsy syndrome	6.43e-05	0.000439	CcSEcCtD
Sufentanil—Vomiting—Topiramate—epilepsy syndrome	6.19e-05	0.000422	CcSEcCtD
Sufentanil—Rash—Topiramate—epilepsy syndrome	6.13e-05	0.000419	CcSEcCtD
Sufentanil—Dermatitis—Topiramate—epilepsy syndrome	6.13e-05	0.000418	CcSEcCtD
Sufentanil—Fentanyl—ABCB1—epilepsy syndrome	6.13e-05	0.0156	CrCbGaD
Sufentanil—Headache—Topiramate—epilepsy syndrome	6.09e-05	0.000416	CcSEcCtD
Sufentanil—Nausea—Topiramate—epilepsy syndrome	5.78e-05	0.000394	CcSEcCtD
Sufentanil—OPRD1—Signaling by GPCR—AGT—epilepsy syndrome	1.41e-05	0.000174	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.4e-05	0.000173	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.4e-05	0.000173	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CHRM2—epilepsy syndrome	1.4e-05	0.000173	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NPY—epilepsy syndrome	1.4e-05	0.000173	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.4e-05	0.000173	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NTRK2—epilepsy syndrome	1.39e-05	0.000172	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SST—epilepsy syndrome	1.39e-05	0.000172	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCR2—epilepsy syndrome	1.39e-05	0.000172	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—DUSP6—epilepsy syndrome	1.38e-05	0.000171	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CDC42—epilepsy syndrome	1.36e-05	0.000169	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.36e-05	0.000168	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AGT—epilepsy syndrome	1.36e-05	0.000168	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GABBR1—epilepsy syndrome	1.36e-05	0.000168	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PLAT—epilepsy syndrome	1.35e-05	0.000168	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HSPB1—epilepsy syndrome	1.35e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—OXT—epilepsy syndrome	1.35e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL2—epilepsy syndrome	1.35e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CRH—epilepsy syndrome	1.35e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL3—epilepsy syndrome	1.35e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCR5—epilepsy syndrome	1.33e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AVP—epilepsy syndrome	1.32e-05	0.000164	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.31e-05	0.000162	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL12—epilepsy syndrome	1.31e-05	0.000162	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—POMC—epilepsy syndrome	1.3e-05	0.000162	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.3e-05	0.000161	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.3e-05	0.000161	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.3e-05	0.000161	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.29e-05	0.00016	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—JUNB—epilepsy syndrome	1.28e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CNR1—epilepsy syndrome	1.28e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PLCB1—epilepsy syndrome	1.28e-05	0.000158	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.25e-05	0.000156	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TSC1—epilepsy syndrome	1.25e-05	0.000155	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTK2B—epilepsy syndrome	1.25e-05	0.000155	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HTR7—epilepsy syndrome	1.25e-05	0.000155	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.24e-05	0.000153	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.24e-05	0.000153	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.24e-05	0.000153	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.24e-05	0.000153	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.24e-05	0.000153	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.24e-05	0.000153	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.24e-05	0.000153	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AGT—epilepsy syndrome	1.23e-05	0.000153	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SST—epilepsy syndrome	1.22e-05	0.000151	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCR2—epilepsy syndrome	1.22e-05	0.000151	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NTRK2—epilepsy syndrome	1.22e-05	0.000151	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HBEGF—epilepsy syndrome	1.21e-05	0.00015	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.21e-05	0.00015	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.21e-05	0.00015	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—DUSP6—epilepsy syndrome	1.21e-05	0.00015	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.19e-05	0.000148	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT3—epilepsy syndrome	1.19e-05	0.000148	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PLAT—epilepsy syndrome	1.19e-05	0.000147	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—POMC—epilepsy syndrome	1.18e-05	0.000147	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NPY—epilepsy syndrome	1.18e-05	0.000146	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.18e-05	0.000146	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ADAM10—epilepsy syndrome	1.16e-05	0.000144	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCL2—epilepsy syndrome	1.16e-05	0.000144	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.15e-05	0.000142	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.14e-05	0.000142	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL12—epilepsy syndrome	1.14e-05	0.000142	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—POMC—epilepsy syndrome	1.14e-05	0.000142	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.14e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.14e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.14e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CRH—epilepsy syndrome	1.14e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—OXT—epilepsy syndrome	1.14e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.14e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.14e-05	0.000141	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.13e-05	0.00014	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.13e-05	0.00014	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.13e-05	0.00014	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.13e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CNR1—epilepsy syndrome	1.12e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—JUNB—epilepsy syndrome	1.12e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.12e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PLCB1—epilepsy syndrome	1.12e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—S100B—epilepsy syndrome	1.1e-05	0.000136	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.1e-05	0.000136	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HTR7—epilepsy syndrome	1.1e-05	0.000136	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SOCS3—epilepsy syndrome	1.09e-05	0.000135	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CDC42—epilepsy syndrome	1.09e-05	0.000135	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HBEGF—epilepsy syndrome	1.06e-05	0.000132	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.06e-05	0.000131	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TSC1—epilepsy syndrome	1.06e-05	0.000131	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTK2B—epilepsy syndrome	1.06e-05	0.000131	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AVP—epilepsy syndrome	1.05e-05	0.00013	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.05e-05	0.00013	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.05e-05	0.00013	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.05e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT3—epilepsy syndrome	1.04e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AGT—epilepsy syndrome	1.04e-05	0.000129	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—POMC—epilepsy syndrome	1.04e-05	0.000129	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NTRK2—epilepsy syndrome	1.03e-05	0.000128	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCR2—epilepsy syndrome	1.03e-05	0.000128	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SST—epilepsy syndrome	1.03e-05	0.000128	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ADAM10—epilepsy syndrome	1.02e-05	0.000126	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DUSP6—epilepsy syndrome	1.02e-05	0.000126	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL2—epilepsy syndrome	1.02e-05	0.000126	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.01e-05	0.000125	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PLAT—epilepsy syndrome	1e-05	0.000124	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HES1—epilepsy syndrome	9.95e-06	0.000123	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—COX3—epilepsy syndrome	9.88e-06	0.000122	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FYN—epilepsy syndrome	9.68e-06	0.00012	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL12—epilepsy syndrome	9.68e-06	0.00012	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	9.68e-06	0.00012	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—POMC—epilepsy syndrome	9.66e-06	0.00012	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—S100B—epilepsy syndrome	9.65e-06	0.00012	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—H2AFX—epilepsy syndrome	9.64e-06	0.00012	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	9.63e-06	0.000119	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MEF2C—epilepsy syndrome	9.63e-06	0.000119	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	9.59e-06	0.000119	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SOCS3—epilepsy syndrome	9.55e-06	0.000118	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CDC42—epilepsy syndrome	9.53e-06	0.000118	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—JUNB—epilepsy syndrome	9.5e-06	0.000118	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CNR1—epilepsy syndrome	9.5e-06	0.000118	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PLCB1—epilepsy syndrome	9.46e-06	0.000117	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PFKL—epilepsy syndrome	9.37e-06	0.000116	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	9.37e-06	0.000116	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	9.37e-06	0.000116	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	9.37e-06	0.000116	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	9.37e-06	0.000116	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—YWHAZ—epilepsy syndrome	9.3e-06	0.000115	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HTR7—epilepsy syndrome	9.27e-06	0.000115	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AVP—epilepsy syndrome	9.23e-06	0.000114	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NGF—epilepsy syndrome	9.2e-06	0.000114	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HBEGF—epilepsy syndrome	9e-06	0.000112	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCR5—epilepsy syndrome	8.95e-06	0.000111	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT3—epilepsy syndrome	8.83e-06	0.000109	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—POMC—epilepsy syndrome	8.77e-06	0.000109	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HTR2A—epilepsy syndrome	8.76e-06	0.000109	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HES1—epilepsy syndrome	8.73e-06	0.000108	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADAM10—epilepsy syndrome	8.62e-06	0.000107	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL2—epilepsy syndrome	8.58e-06	0.000106	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—UPB1—epilepsy syndrome	8.57e-06	0.000106	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ATIC—epilepsy syndrome	8.57e-06	0.000106	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NEU1—epilepsy syndrome	8.57e-06	0.000106	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FYN—epilepsy syndrome	8.49e-06	0.000105	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—H2AFX—epilepsy syndrome	8.46e-06	0.000105	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MEF2C—epilepsy syndrome	8.44e-06	0.000105	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TSC2—epilepsy syndrome	8.32e-06	0.000103	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AGT—epilepsy syndrome	8.31e-06	0.000103	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	8.25e-06	0.000102	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—YWHAZ—epilepsy syndrome	8.16e-06	0.000101	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	8.15e-06	0.000101	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOE—epilepsy syndrome	8.14e-06	0.000101	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	8.08e-06	0.0001	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NGF—epilepsy syndrome	8.07e-06	0.0001	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	8.06e-06	9.99e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KDR—epilepsy syndrome	7.98e-06	9.89e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GBE1—epilepsy syndrome	7.96e-06	9.87e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	7.96e-06	9.87e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCR5—epilepsy syndrome	7.85e-06	9.73e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	7.8e-06	9.67e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HTR2A—epilepsy syndrome	7.68e-06	9.52e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PRKCB—epilepsy syndrome	7.68e-06	9.52e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6ST—epilepsy syndrome	7.65e-06	9.48e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	7.49e-06	9.28e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	7.38e-06	9.14e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TSC2—epilepsy syndrome	7.29e-06	9.04e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AGT—epilepsy syndrome	7.29e-06	9.03e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	7.28e-06	9.03e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	7.17e-06	8.89e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	7.15e-06	8.86e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOE—epilepsy syndrome	7.14e-06	8.85e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	7.13e-06	8.84e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NT5E—epilepsy syndrome	7.1e-06	8.8e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALAD—epilepsy syndrome	7.1e-06	8.8e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KDR—epilepsy syndrome	6.99e-06	8.67e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—POMC—epilepsy syndrome	6.99e-06	8.67e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	6.89e-06	8.55e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL2—epilepsy syndrome	6.84e-06	8.48e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	6.82e-06	8.45e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	6.77e-06	8.39e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	6.77e-06	8.39e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PRKCB—epilepsy syndrome	6.73e-06	8.35e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6ST—epilepsy syndrome	6.7e-06	8.31e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	6.63e-06	8.22e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	6.63e-06	8.21e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ADSL—epilepsy syndrome	6.49e-06	8.05e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	6.49e-06	8.04e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GLUL—epilepsy syndrome	6.37e-06	7.89e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	6.25e-06	7.75e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FGF2—epilepsy syndrome	6.18e-06	7.67e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	6.17e-06	7.64e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	6.16e-06	7.63e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—POMC—epilepsy syndrome	6.13e-06	7.6e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	6.03e-06	7.48e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL2—epilepsy syndrome	6e-06	7.44e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	5.91e-06	7.33e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	5.85e-06	7.25e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RELA—epilepsy syndrome	5.74e-06	7.12e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	5.69e-06	7.05e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AQP1—epilepsy syndrome	5.67e-06	7.03e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	5.67e-06	7.02e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MTOR—epilepsy syndrome	5.63e-06	6.98e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGF2—epilepsy syndrome	5.42e-06	6.72e-05	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.23e-06	6.48e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	5.18e-06	6.42e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CASP3—epilepsy syndrome	5.18e-06	6.42e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.13e-06	6.36e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.13e-06	6.36e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	5.07e-06	6.29e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RELA—epilepsy syndrome	5.03e-06	6.24e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	5.03e-06	6.23e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	4.94e-06	6.12e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	4.89e-06	6.07e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	4.75e-06	5.88e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	4.58e-06	5.68e-05	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.58e-06	5.68e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	4.54e-06	5.63e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	4.51e-06	5.59e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	4.41e-06	5.47e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	4.39e-06	5.45e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	4.29e-06	5.32e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	4.25e-06	5.27e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.18e-06	5.19e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	4.17e-06	5.17e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	4.16e-06	5.16e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.08e-06	5.05e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.05e-06	5.02e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	3.96e-06	4.9e-05	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.87e-06	4.8e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	3.85e-06	4.78e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	3.84e-06	4.76e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	3.73e-06	4.62e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.66e-06	4.53e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	3.63e-06	4.5e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	3.52e-06	4.36e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.48e-06	4.32e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.47e-06	4.3e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	3.34e-06	4.14e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.31e-06	4.1e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.27e-06	4.05e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TH—epilepsy syndrome	3.26e-06	4.04e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	3.26e-06	4.04e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	2.8e-06	3.48e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.72e-06	3.37e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.68e-06	3.33e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.61e-06	3.24e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	2.46e-06	3.05e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.43e-06	3.01e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.13e-06	2.64e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.09e-06	2.59e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.08e-06	2.58e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.79e-06	2.22e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.63e-06	2.02e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.43e-06	1.77e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.18e-07	8.9e-06	CbGpPWpGaD
